MPS Powered by Eureka

Forgot your password?

To find the most relevant journal, please insert appropriate keyword to facilitate search.

 

Type keyword

Search Results: cmp



Download Flyer

Current Molecular Pharmacology

Start Submission

ISSN: 1874-4702

Journal
Impact Factor :

2.4

Scopus
CiteScore:

4.9

Aims and Scope:Current Molecular Pharmacology aims to publish the latest developments in cellular and molecular pharmacology with a major emphasis on the mechanism of action of novel drugs under development, innovative pharmacological technologies, cell signaling, transduction pathway analysis, genomics, proteomics, and metabonomics applications to drug action. An additional focus will be the way in which normal biological function is illuminated by knowledge of the action of drugs at the cellular and molecular level. The journal publishes full-length/mini reviews, original research articles and thematic issues on molecular pharmacology. Current Molecular Pharmacology is an essential journal for every scientist who is involved in drug design and discovery, target identification, target validation, preclinical and clinical development of drugs therapeutically useful in human disease.

Editor-in-Chief:

DA Gewirtz
Virginia Commonwealth University Health System, Richmond, , United States

Indexed in:


Scopus, SCI Expanded, MEDLINE/PubMed... View all

Special Issues With Active Call for Papers

Submission closes on: Dec 31, 2025
Common Mechanisms Underpinning Neurodevelopmental Disorders and Psychiatric Diseases

A growing number of large-scale epidemiologic studies have strongly suggested that common mechanisms may be shared by aberrant brain development and psychiatric disorders. There is now an appreciation of the synergic roles of genetic variants and environmental stress, which profoundly affect genome integrity and reshape brain development. This can lead to transient or stable changes in the organization of neural networks, which co-segregates with neurodevelopmental and psychiatric disorders in which a plethora of questions yet... see more

Impact Factor: 2.4
Guest Editor(s): Dr. Bing Lang
Co-Guest Editor(s): Dr. Ling Hu Hu,Dr. Chizu Nakamoto Nakamoto,Dr. Wenbin Guo Guo
Start Submission
Submission closes on: Dec 31, 2025
New Cell Death Regulation Drugs for Cardiovascular Diseases

Cardiovascular diseases are the leading cause of mortality worldwide, with aberrant cell death processes playing a crucial role in their pathogenesis. Cell death in these diseases encompasses not only well-studied forms of apoptosis but also includes a variety of complex modes such as mitochondrial permeability transition (MPT)-driven necrosis, entotic cell death, necroptosis, ferroptosis, pyroptosis, and PARP-1-dependent cell death (parthanatos). These modes of cell death exhibit unique regulatory mechanisms and biological consequences within the pathological state... see more

Impact Factor: 2.4
Guest Editor(s): Yao Chen
Co-Guest Editor(s): Dr. Canzhao Liu,Dr. Changjun Yin,Dr. Rongjun Zou
Start Submission
Submission closes on: Dec 31, 2025
Advances in the Diagnosis and Treatment of Head and Neck Disease

Head and neck diseases encompass a wide range of conditions affecting the oral cavity, pharynx, larynx, nasal passages, sinuses, salivary glands, and other structures of the head and neck region. These diseases can have significantly on essential function, such as breathing, swallowing, speaking, as well as the quality of life. Head and neck diseases not only include cancer, but also involves infection, benign tumors and so on. So, it is of great significance to explore... see more

Impact Factor: 2.4
Guest Editor(s): Wei-Wei Deng
Co-Guest Editor(s): Lei-Lei Yang
Start Submission